Speedel shareholders elect four Novartis officers as new members to the board of directors
Speedel Holding Ltd. (SWX: SPPN) today announced the outcome of the Extraordinary General Meeting (EGM) of the sharehold…
Speedel Holding Ltd. (SWX: SPPN) today announced the outcome of the Extraordinary General Meeting (EGM) of the sharehold…
Speedel Holding Ltd. (SWX: SPPN) today announced financial results for the second quarter and the first six months endin…
Speedel Holding Ltd. (SWX: SPPN) today announced the recommendation of the Board of Directors regarding the public tende…
Speedel Holding Ltd. (SWX: SPPN) today published the invitation for the Extraordinary General Meeting (EGM) to be held o…
Speedel Holding Ltd. (SWX: SPPN) today announced that data for two of its developmental product candidates were presente…
Speedel Holding Ltd. (SWX: SPPN) highlighted today that it is actively participating in Hypertension 2008, a joint meeti…
Data from the AVOID study published in this week's New England Journal of Medicine demonstrate that the first-in-class d…
Speedel Holding Ltd (SWX: SPPN) today announced that it has received from Novartis the royalty report regarding SPP100/A…
Speedel Holding Ltd. (SWX: SPPN) today announced financial results for the three months ending 31 March 2008. Financi…
Speedel (SWX: SPPN) today welcomed promising results from the latest SPP100 (Tekturna/Rasilez[1]) surrogate marker clin…